Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

NCT00075946 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

545

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]